{"id":"https://openalex.org/W35357945","doi":null,"title":"Steady-state anticonvulsant drug levels in epileptic patients.","display_name":"Steady-state anticonvulsant drug levels in epileptic patients.","alternate_titles":[],"publication_year":1996,"publication_date":"1996-10-01","ids":{"openalex":"https://openalex.org/W35357945","mag":"35357945","pmid":"https://pubmed.ncbi.nlm.nih.gov/8997850"},"language":"en","primary_location":{"id":"pmid:8997850","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8997850","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"East African medical journal","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W35357945"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5074925860","display_name":"Gilbert O. Kokwaro","orcid":"https://orcid.org/0000-0001-8981-2379","observed_orcids":["https://orcid.org/0000-0001-8981-2379"]},"institutions":[{"id":"https://openalex.org/I12859529","display_name":"University of Nairobi","ror":"https://ror.org/02y9nww90","country_code":"KE","type":"education","lineage":["https://openalex.org/I12859529"]}],"countries":["KE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"G O Kokwaro","raw_affiliation_strings":["Department of Pharmaceutics and Pharmacy Practice, Faculty of Pharmacy, College of Health Sciences, University of Nairobi, Kenya"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics and Pharmacy Practice, Faculty of Pharmacy, College of Health Sciences, University of Nairobi, Kenya","institution_ids":["https://openalex.org/I12859529"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109949718","display_name":"T O Kwasa","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"T O Kwasa","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048307735","display_name":"Anne Indalo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A A Indalo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5047557022","display_name":"Isaac Ongubo Kibwage","orcid":"https://orcid.org/0000-0003-1257-8750","observed_orcids":["https://orcid.org/0000-0003-1257-8750"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"I O Kibwage","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.00453754,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"73","issue":"10","first_page":"679","last_page":"682"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12229","display_name":"Pharmacological Effects and Toxicity Studies","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antiepileptic-drugs","display_name":"antiepileptic drugs","score":0.8769999742507935},{"id":"https://openalex.org/keywords/phenobarbital","display_name":"phenobarbital","score":0.8820000290870667},{"id":"https://openalex.org/keywords/phenytoin","display_name":"phenytoin","score":1.0},{"id":"https://openalex.org/keywords/carbamazepine","display_name":"carbamazepine","score":1.0},{"id":"https://openalex.org/keywords/epilepsy","display_name":"epilepsy","score":0.9520000219345093},{"id":"https://openalex.org/keywords/drug-monitoring","display_name":"drug monitoring","score":0.5090000033378601},{"id":"https://openalex.org/keywords/unbound-fraction","display_name":"unbound fraction","score":0.5619999766349792},{"id":"https://openalex.org/keywords/albumin-levels","display_name":"albumin levels","score":0.6209999918937683},{"id":"https://openalex.org/keywords/total-protein","display_name":"total protein","score":0.4620000123977661},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.6340000033378601}],"concepts":[{"id":"https://openalex.org/C2778337148","wikidata":"https://www.wikidata.org/wiki/Q410400","display_name":"Phenytoin","level":3,"score":0.9360916614532471},{"id":"https://openalex.org/C2779253243","wikidata":"https://www.wikidata.org/wiki/Q410412","display_name":"Carbamazepine","level":3,"score":0.8523037433624268},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8202923536300659},{"id":"https://openalex.org/C2775858608","wikidata":"https://www.wikidata.org/wiki/Q576618","display_name":"Anticonvulsant","level":3,"score":0.8141399621963501},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.6001999974250793},{"id":"https://openalex.org/C2778793413","wikidata":"https://www.wikidata.org/wiki/Q407241","display_name":"Phenobarbital","level":2,"score":0.5131762623786926},{"id":"https://openalex.org/C2776125364","wikidata":"https://www.wikidata.org/wiki/Q169219","display_name":"Albumin","level":2,"score":0.4953814744949341},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.46489280462265015},{"id":"https://openalex.org/C2781233306","wikidata":"https://www.wikidata.org/wiki/Q5500236","display_name":"Free fraction","level":3,"score":0.4515409469604492},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.3989112377166748},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.37186723947525024},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.34998607635498047},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3325411081314087},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3267151713371277},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.06784713268280029}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D004827","descriptor_name":"Epilepsy","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D004827","descriptor_name":"Epilepsy","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010349","descriptor_name":"Patient Compliance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016527","descriptor_name":"Drug Costs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016903","descriptor_name":"Drug Monitoring","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:8997850","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8997850","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"East African medical journal","raw_type":"Journal Article"},{"id":"mag:35357945","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8997850","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2076024851","https://openalex.org/W32075591","https://openalex.org/W1963630244","https://openalex.org/W2023977986","https://openalex.org/W2409208903","https://openalex.org/W2071290527","https://openalex.org/W2354143346","https://openalex.org/W2408402740","https://openalex.org/W2150760847","https://openalex.org/W2912107764"],"abstract_inverted_index":{"Steady":[0],"state":[1,112],"concentrations":[2,113],"of":[3,135,179,192,199],"three":[4,92],"anticonvulsant":[5,193],"drugs":[6],"(phenobarbitone,":[7],"phenytoin":[8,95,108,136],"and":[9,21,44,91,109,125,163],"carbamazepine)":[10],"were":[11,47,58,74,114,172],"measured":[12,48],"in":[13,49,63,67,80,101,137,143,150,155],"plasma":[14,50,138],"samples":[15],"from":[16,51,176],"fifteen":[17],"patients":[18,52,65,82,93,154],"(eight":[19],"males":[20],"seven":[22],"females;":[23],"ages:":[24],"13-49":[25],"years;":[26],"body":[27],"weights:":[28],"44-70":[29],"kg),":[30],"attending":[31],"the":[32,105,156,160],"outpatient":[33],"Neurology":[34],"Clinic":[35],"at":[36],"Kenyatta":[37],"National":[38],"Hospital.":[39],"In":[40,104],"addition,":[41],"total":[42],"protein":[43,56],"albumin":[45],"levels":[46,57,73,100,171,195],"taking":[53],"phenytoin.":[54],"Total":[55],"normal":[59,76],"(range:":[60,77],"6.3-7.6":[61],"g/dl)":[62,79],"all":[64,81,183],"except":[66,83],"one":[68,84,151],"patient":[69,88],"(10.7":[70],"g/dl).":[71,86],"Albumin":[72],"also":[75],"3.7-4.1":[78],"(25.4":[85],"One":[87],"on":[89,94],"phenobarbitone":[90],"had":[96],"no":[97],"detectable":[98],"drug":[99,170,194],"their":[102,164],"plasma.":[103],"remainder,":[106],"phenobarbitone,":[107],"carbamazepine":[110],"steady":[111],"8.7-21.1":[115],"mg/L":[116,121,127],"(N":[117,122,128],"=":[118,123,129],"8),":[119],"9.3-27.3":[120],"6)":[124],"10-19.7":[126],"5),":[130],"respectively.":[131],"The":[132],"unbound":[133],"fraction":[134],"(fu)":[139],"was":[140,166],"normal(approximately":[141],"0.1)":[142],"six":[144],"patients,":[145],"but":[146],"relatively":[147],"high":[148],"(0.2)":[149],"patient.":[152],"Most":[153],"study":[157],"complied":[158],"with":[159],"prescribed":[161,184],"treatment":[162],"epilepsy":[165],"controlled.":[167],"Cases":[168],"where":[169],"undetectable":[173],"probably":[174],"arose":[175],"a":[177],"lack":[178],"money":[180],"to":[181],"purchase":[182],"medicines":[185],"rather":[186],"than":[187],"deliberate":[188],"non-compliance.":[189],"Routine":[190],"monitoring":[191],"may":[196],"improve":[197],"management":[198],"epileptic":[200],"patients.":[201]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W35357945","counts_by_year":[],"updated_date":"2026-11-15T12:55:33.944570","created_date":"2016-06-24T00:00:00"}
